Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. [electronic resource]
Producer: 20090930Description: 490-5 p. digitalISSN:- 1442-9071
- Adult
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Aqueous Humor -- metabolism
- Bevacizumab
- Enzyme-Linked Immunosorbent Assay
- Eye Proteins -- metabolism
- Female
- Humans
- Macular Edema -- drug therapy
- Male
- Middle Aged
- Nerve Growth Factors -- metabolism
- Prognosis
- Retinal Vein Occlusion -- complications
- Serpins -- metabolism
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.